Consulters ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.7% 11.9% 36.2% 16.5% 12.5%  
Credit score (0-100)  31 19 0 10 19  
Credit rating  BB BB C BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  973 1,009 827 550 347  
EBITDA  38.5 0.5 -281 213 55.7  
EBIT  38.5 0.5 -281 213 55.7  
Pre-tax profit (PTP)  37.1 -7.4 -283.9 209.8 51.7  
Net earnings  25.7 -9.9 -283.9 209.8 40.9  
Pre-tax profit without non-rec. items  37.1 -7.4 -284 210 51.7  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  331 131 -153 57.0 97.9  
Interest-bearing liabilities  147 164 0.0 139 143  
Balance sheet total (assets)  906 529 121 302 333  

Net Debt  -348 36.0 -45.3 97.9 75.1  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  973 1,009 827 550 347  
Gross profit growth  92.1% 3.7% -18.0% -33.5% -36.8%  
Employees  2 3 3 3 1  
Employee growth %  100.0% 50.0% 0.0% 0.0% -66.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  906 529 121 302 333  
Balance sheet change%  85.1% -41.6% -77.2% 150.0% 10.4%  
Added value  38.5 0.5 -281.0 213.0 55.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  5.0 5.0 -1.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.0% 0.0% -34.0% 38.7% 16.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.9% 0.4% -70.0% 74.8% 18.4%  
ROI %  9.9% 0.7% -190.2% 219.1% 26.7%  
ROE %  8.1% -4.3% -225.5% 236.1% 52.8%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  36.5% 24.7% -55.9% 18.9% 29.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -904.3% 7,202.8% 16.1% 46.0% 134.7%  
Gearing %  44.5% 125.6% 0.0% 244.8% 145.9%  
Net interest  0 0 0 0 0  
Financing costs %  3.9% 6.6% 3.5% 7.7% 4.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.6 1.3 0.4 1.2 1.4  
Current Ratio  1.6 1.3 0.4 1.2 1.4  
Cash and cash equivalent  495.2 128.5 45.3 41.5 67.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  330.9 122.8 -169.1 57.0 97.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  19 0 -94 71 56  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  19 0 -94 71 56  
EBIT / employee  19 0 -94 71 56  
Net earnings / employee  13 -3 -95 70 41